RECURRENT LYMPHOMA
Clinical trials for RECURRENT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with aggressive brain tumors: experimental drug trial opens
Disease control Recruiting nowThis early-stage trial is testing a new drug called CBL0137 in children and young adults (ages 1-21) whose solid tumors, brain tumors, or lymphoma have come back or stopped responding to standard treatments. The main goals are to find the safest dose and see if the drug can help …
Matched conditions: RECURRENT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Mega-Dose vitamin c joins fight against stubborn blood cancers
Disease control Recruiting nowThis study is testing if adding high-dose vitamin C (given through an IV) to standard chemotherapy can help patients whose lymphoma has returned or hasn't responded to treatment. It also tests vitamin C alone for certain pre-leukemia conditions. The goal is to see if vitamin C ma…
Matched conditions: RECURRENT LYMPHOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC